Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Denali Therapeutics	Alector	Fate Therapeutics	Bill.com	Regenxbio
Symbol	NASDAQ:DNLI	NASDAQ:ALEC	NASDAQ:FATE	NASDAQ:RVMD	NASDAQ:RGNX
Price Information
Current Price	$18.60	$23.73	$25.46	$23.02	$31.36
52 Week Range	Buy	Buy	Buy	Buy	Buy
Analyst Ratings
Consensus Recommendation	Buy	Buy	Buy	Buy	Buy
Consensus Price Target	$29.67	$28.00	$35.44	$41.00	$76.75
% Upside from Price Target	59.50% upside	17.99% upside	39.19% upside	78.11% upside	144.74% upside
Trade Information
Market Cap	$1.91 billion	$1.85 billion	$1.74 billion	$1.40 billion	$1.15 billion
Beta	1.8	1.24	1.8	N/A	1.04
Average Volume	741,010	651,620	1,170,019	489,311	535,176
Sales & Book Value
Annual Revenue	$26.68 million	$21.22 million	$10.68 million	N/A	$35.23 million
Price / Sales	73.50	87.81	181.03	N/A	33.06
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	$4.11 per share	$2.83 per share	$3.24 per share	N/A	$12.23 per share
Price / Book	4.53	8.39	7.86	N/A	2.56
Profitability
Net Income	$-197,610,000.00	$-105,390,000.00	$-98,150,000.00	N/A	$-94,730,000.00
EPS	($2.07)	($1.71)	($1.44)	N/A	($3.26)
Trailing P/E Ratio	N/A	N/A	N/A	0.00	N/A
Forward P/E Ratio	N/A	N/A	N/A	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	-740.74%	-496.65%	-919.00%	N/A	-268.88%
Return on Equity (ROE)	-43.31%	-45.56%	-49.94%	N/A	-25.21%
Return on Assets (ROA)	-32.00%	-22.85%	-36.92%	N/A	-23.31%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.17%	0.21%	0.10%	N/A	0.02%
Current Ratio	9.48%	5.77%	8.17%	N/A	10.25%
Quick Ratio	9.48%	5.77%	8.17%	N/A	10.25%
Ownership Information
Institutional Ownership Percentage	67.08%	53.54%	95.07%	N/A	80.84%
Insider Ownership Percentage	21.20%	13.90%	21.41%	N/A	13.80%
Miscellaneous
Employees	179	91	104	N/A	192
Shares Outstanding	105.42 million	78.53 million	75.94 million	59.00 million	37.14 million
Next Earnings Date	5/13/2020 (Estimated)	5/11/2020 (Estimated)	5/5/2020 (Estimated)	N/A	5/5/2020 (Estimated)
Optionable	Optionable	Not Optionable	Optionable	Not Optionable	Optionable

Comparison Ideas:

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

Start Your Free Trial Today

Market Data and Calendars

Investing Education and Resources